D.A. Davidson & Co’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.2M	Buy	93,260 +9,260	+11%	+$118K	0.01%	864
2025 Q4	$755K	Buy	84,000 +19,780	+31%	+$272K	﹤0.01%	991
2025 Q3	$1.11M	Buy	64,220 +10,100	+19%	+$124K	0.01%	826
2025 Q2	$508K	Buy	54,120 +28,100	+108%	+$231K	﹤0.01%	1052
2025 Q1	$185K	Buy	26,020 +11,250	+76%	+$114K	﹤0.01%	1333
2024 Q4	$172K	Sell	14,770 -1,480	-9%	-$23.1K	﹤0.01%	1354
2024 Q3	$334K	Buy	16,250 +4,150	+34%	+$95.7K	﹤0.01%	1152
2024 Q2	$271K	Buy	+12,100	New	+$288K	﹤0.01%	1202
2018 Q4	–	Sell	-10,166	Closed	-$291K	–	1146
2018 Q3	$291K	Sell	10,166 -8,729	-46%	-$254K	0.01%	924
2018 Q2	$517K	Sell	18,895 -324	-2%	-$7.85K	0.01%	692
2018 Q1	$405K	Buy	19,219 +2,395	+14%	+$58.9K	0.01%	761
2017 Q4	$323K	Buy	+16,824	New	+$388K	0.01%	812